2017
DOI: 10.5812/jjm.12800
|View full text |Cite
|
Sign up to set email alerts
|

Epstein-Barr Virus and Breast Carcinoma in Iran

Abstract: Background: A viral etiology for several malignancies has been suggested. One of the risk factors for development of breast carcinoma, which is the leading malignancy in women all over the world, is proposed to be a viral infection; hence recognition of the causative issues is essential for proper management.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 16 publications
(19 reference statements)
0
3
1
Order By: Relevance
“…For EBV, the screening of the viral genome did not show any correlation with the case and control groups (P = 0.164) ( Table 3). The rate of EBV infection in breast cancer patients was not unexpected, as the virus has been detected in many studies to be absent or be at a low rate at this site (45)(46)(47). However, we did not observe any significant association between breast cancer and EBV presence.…”
Section: Discussioncontrasting
confidence: 48%
“…For EBV, the screening of the viral genome did not show any correlation with the case and control groups (P = 0.164) ( Table 3). The rate of EBV infection in breast cancer patients was not unexpected, as the virus has been detected in many studies to be absent or be at a low rate at this site (45)(46)(47). However, we did not observe any significant association between breast cancer and EBV presence.…”
Section: Discussioncontrasting
confidence: 48%
“…Overall, 6.8% (7/102) of samples comprised 11.76% (6/51) in malignant tissues and 1.9% (1/51) in adjacent non-malignant tissues found to be positive for presence of EBV genome, which was statistically significant (P<0.05).Similar to our results, several case-control reports from Iran and other parts of the world have demonstrated higher prevalence of EBV in malignant tumors as compared with control groups. In several studies, the prevalence rate of EBV in malignant breast tissues and nonmalignant control groups were as follows: 9.3% and 0% in a study by Aghdam et al (Iran, 2017), 8% and 0% in a study by Malekpour et al (Iran, 2015), 5.1% and 0% in a study by Saeedi et al (Iran, 2018), 10% and 0% in a study by Antonsson et al (Australia, 2012), 13.6% and 4.5% in a study by Ladera et al (Venezuela, 2017), respectively (28)(29)(30)(31)(32). It is noteworthy that despite other investigations, our study used adjacent non-malignant tissues to improve the accuracy of viral causality in the development of malignancy.…”
Section: Discussionmentioning
confidence: 88%
“…They suggested that EBV may have an etiologic role in breast cancer in Iran. 39 Joshi et al applied Immunohistochemistry and commercial enzyme-linked Immunosorbent assay (ELISA) kit and showed EBNA-1 expression in a significant proportion of breast cancer tissues from rural India. These patients also have a higher immunological response against EBNA-1 33.…”
Section: Discussionmentioning
confidence: 99%